US 12091462
Antibodies binding to vista at acidic pH
granted A61KA61K2039/507A61P
Quick answer
US patent 12091462 (Antibodies binding to vista at acidic pH) held by Five Prime Therapeutics, Inc. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/507, A61P, A61P35/00, A61P35/02